DIGOXIN

To receive automatic updates of Nursing News, Nursing Care Plans, Case Studies and the November 2008 Nursing Board Exam Result: click Subscribe to NursingCrib.com by Email or via RSS. If you have other topics to discuss, make a post on our Nursing Crib Forum. Thanks for visiting and enjoy your stay!

(di-jox’in)
Lanoxicaps, Lanoxin
Classifications: cardiovascular agent; cardiac glycoside; antiarrhythmic
Pregnancy Category: A

NURSING IMPLICATIONS

Assessment & Drug Effects

• Be familiar with patient’s baseline data (e.g., quality of peripheral pulses, blood pressure, clinical symptoms, serum electrolytes, creatinine clearance) as a foundation for making assessments.
• Lab tests: Baseline and periodic serum digoxin, potassium, magnesium, and calcium. Notify physician of abnormal values. Draw blood samples for determining plasma digoxin levels at least 6 h after daily dose and preferably just before next scheduled daily dose. Therapeutic range of serum digoxin is 0.8–2 ng/mL; toxic levels are >2 ng/mL.
• Take apical pulse for 1 full min noting rate, rhythm, and quality before administering. If changes are noted, withhold digoxin, take rhythm strip if patient is on ECG monitor, notify physician promptly.
• Withhold medication and notify physician if apical pulse falls below ordered parameters (e.g., >50 or 60/min in adults and >60 or 70/min in children).
• Monitor for S&S of drug toxicity: In children, cardiac arrhythmias are usually reliable signs of early toxicity. Early indicators in adults (anorexia, nausea, vomiting, diarrhea, visual disturbances) are rarely initial signs in children.
• Monitor I&O ratio during digitalization, particularly in patients with impaired renal function. Also monitor for edema daily and auscultate chest for rales.
• Monitor serum digoxin levels closely during concurrent antibiotic–digoxin therapy, which can precipitate toxicity because of altered intestinal flora.
• Observe patients closely when being transferred from one preparation (tablet, elixir, or parenteral) to another; when tablet is replaced by elixir potential for toxicity increases since 30% of drug is absorbed.

Patient & Family Education

• Report to physician if pulse falls below 60 or rises above 110 or if you detect skipped beats or other changes in rhythm, when digoxin is prescribed for atrial fibrillation.
• Suspect toxicity and report to physician if any of the following occur: Anorexia, nausea, vomiting, diarrhea, or visual disturbances.
• Weigh each day under standard conditions. Report weight gain >1 kg (2 lb)/d.
• Take digoxin PRECISELY as prescribed, do not skip or double a dose or change dose intervals, and take it at same time each day.
• Do not to take OTC medications, especially those for coughs, colds, allergy, GI upset, or obesity, without prior approval of physician.
• Continue with brand originally prescribed unless otherwise directed by physician.
• Do not breast feed while taking this drug without consulting physician.

Other Nursing Articles you may want to look at:

• SPIRONOLACTONE (speer-on-oh-lak’tone) Aldactone, Novospiroton  Classifications: electrolytic and water balance agent; potassium-sparing diuretic Pregnancy Category: D NURSING IMPLICATIONS Assessment & Drug Effects Check blood pressure before initiation of therapy and at regular intervals throughout therapy. Lab tests: Monitor serum electrolytes (sodium and potassium) especially during early therapy; monitor digoxin
• PIPERACILLIN SODIUM (pi-per’a-sill-in) Pipracil Classifications: antiinfective; beta-lactam antibiotic; antipseudomonal penicillin Prototype: Mezlocillin Pregnancy Category: B NURSING IMPLICATIONS Assessment & Drug Effects Obtain history of hypersensitivity to penicillins, cephalosporins, or other drugs prior to administration. Lab tests: C&S prior to first dose of the drug; start drug pending results. Periodic CBC
• EPINEPHRINE (ep-i-ne’frin) Bronkaid Mist, Epi-E-Zpen, Epinephrine Pediatric, EpiPen Auto-Injector, Primatene Mist Suspension EPINEPHRINE BITARTRATE AsthmaHaler, Bronkaid Mist Suspension, Bronitin Mist Suspension, Epitrate, Medihaler-Epi, Primatene Mist Suspension EPINEPHRINE HYDROCHLORIDE Adrenalin Chloride, Bronkaid Mistometer, Dysne-Inhal, Epifrin, Glaucon, SusPhrine   NURSING IMPLICATIONS Assessment & Drug Effects Monitor BP, pulse, respirations, and urinary output and observe patient closely following IV
• CORTICOSTEROIDS NURSING IMPLICATIONS Assessment & Drug Effects Establish baseline and continuing data on BP, weight, fluid and electrolyte balance, and blood glucose. Lab tests: Periodic serum electrolytes blood glucose, Hct and Hgb, platelet count, and WBC with differential. Monitor for
• AMLODIPINE (am-lo’di-peen) Norvasc Classifications: cardiovascular agent; calcium channel blocker; antihypertensive agent Prototype: Nifedipine Pregnancy Category: C NURSING IMPLICATIONS Assessment & Drug Effects Monitor BP for therapeutic effectiveness. BP reduction is greatest after peak levels of amlodipine are achieved 6–9 h following oral doses. Monitor for S&S of dose-related peripheral